Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Central memory CD8+ T lymphocytes mediate lung allograft acceptance
Alexander Sasha Krupnick, … , Andrew E. Gelman, Daniel Kreisel
Alexander Sasha Krupnick, … , Andrew E. Gelman, Daniel Kreisel
Published February 24, 2014
Citation Information: J Clin Invest. 2014;124(3):1130-1143. https://doi.org/10.1172/JCI71359.
View: Text | PDF
Research Article

Central memory CD8+ T lymphocytes mediate lung allograft acceptance

  • Text
  • PDF
Abstract

Memory T lymphocytes are commonly viewed as a major barrier for long-term survival of organ allografts and are thought to accelerate rejection responses due to their rapid infiltration into allografts, low threshold for activation, and ability to produce inflammatory mediators. Because memory T cells are usually associated with rejection, preclinical protocols have been developed to target this population in transplant recipients. Here, using a murine model, we found that costimulatory blockade–mediated lung allograft acceptance depended on the rapid infiltration of the graft by central memory CD8+ T cells (CD44hiCD62LhiCCR7+). Chemokine receptor signaling and alloantigen recognition were required for trafficking of these memory T cells to lung allografts. Intravital 2-photon imaging revealed that CCR7 expression on CD8+ T cells was critical for formation of stable synapses with antigen-presenting cells, resulting in IFN-γ production, which induced NO and downregulated alloimmune responses. Thus, we describe a critical role for CD8+ central memory T cells in lung allograft acceptance and highlight the need for tailored approaches for tolerance induction in the lung.

Authors

Alexander Sasha Krupnick, Xue Lin, Wenjun Li, Ryuiji Higashikubo, Bernd H. Zinselmeyer, Hollyce Hartzler, Kelsey Toth, Jon H. Ritter, Mikhail Y. Berezin, Steven T. Wang, Mark J. Miller, Andrew E. Gelman, Daniel Kreisel

×

Figure 3

CD4+ T lymphocyte responses in CSB-treated lung transplant recipients.

Options: View larger image (or click on image) Download as PowerPoint
CD4+ T lymphocyte responses in CSB-treated lung transplant recipients.
 ...
(A) The proportion of lung-resident CD4+Foxp3+ T cells is not different in resting B6 and B6 Cd8–/– lungs. These numbers do increase, however, after allograft transplantation, and a higher abundance of graft-infiltrating CD4+Foxp3+ T cells is detectable in B6 compared with B6 Cd8–/– lung graft recipients (comparison between resting and transplanted lungs by ANOVA and comparison between B6 and B6 Cd8–/– groups by unpaired t test). (B) Proliferation of B6 CD4+CD45.1+ T cells was greater after injection into B6 Cd8–/– (51.3% ± 5%) than B6 wild-type (20.6% ± 4%) recipients (P = 0.0017 by unpaired t test). Proliferating CD4+CD45.1+ T cells in B6 Cd8–/– recipients upregulated CD27, ICOS, and OX40 but not CD28 or CD154 compared with wild-type mice. Numbers in contour plots represent the percentages of adoptively transferred CD4+CD45.1+ T cells that have undergone proliferation (shaded gray, isotype controls; black lines, B6 wild-type; red lines, B6 Cd8–/– recipients). (C) Inhibiting CD27/CD70, ICOS/ICOS ligand, and OX40/OX40 ligand in addition to blocking CD40/CD154 and CD28/B7 does not prevent rejection in the absence of CD8+ T cells (P = 0.00074 vs. Figure 2A by Mantel-Haenszel χ2 test). All gross and histological appearances as well as rejection grades represent grafts at 7 days after transplantation (original magnification, ×200 [histology, H&E staining]). TXP denotes graft, and the arrow points to perivascular infiltrates.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts